(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CIMBAN

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

CIMBAN

ST13

US500000098558902

Classe

1, 42

Pedido

98558902

Registro

7806705

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

15

Atualização mais recente

27/05/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 42

Data de depósito

20/05/2024

Data de registro

27/05/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

27/05/2025

Última transação

27/05/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Foreign priority

Código do desenho

4

Tipo de titular

16

Localização do titular

SAFFRON WALDEN, Essex, GB

Examinador

TAYLOR, SLOAN H

Unidade examinadora

O20

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Camena Bioscience Limited

Representantes

Jeffrey H. Greene Foley & Lardner LLP

Classificação técnica

Classes Nice

Classe 1Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemicals for use in the biochemical and chemical industry; Chemical substances for use in the production of drugs, pharmaceuticals and antibodies; Active chemical ingredients for use in the production of drugs, pharmaceuticals and antibodies; DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for scientific and research use; Nucleic acids comprising synthetic nucleotides for scientific and research use; Synthetic DNA nucleotides, synthetic RNA nucleotides, synthetic genes being biotechnologically formed genes, synthetic oligonucleotides and synthetic proteins for laboratory, scientific and industrial use; Chemical preparations, namely, synthetic enzymes, gene editing enzymes, DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for laboratory, scientific and industrial purposes; Synthetic DNA and RNA nucleotides for scientific and medical research; synthetic DNA nucleotides, RNA nucleotides, XNA nucleotides, biotechnologically formed genes, oligonucleotides and proteins for use in medical biologics and therapeutics; Molecular biology research tools in the nature of chemical, biological and biochemical reagents used for the synthesis of DNA, RNA, XNA, oligonucleotides, genes and proteins.

Classe 42

Consultancy in relation to biochemistry and biotechnology; Research and development in the field of biotechnology and synthetic biology; Biological analysis; Biotechnological research relating to enzymatic synthesis; Provision of gene synthesis solutions, namely, creating and modifying genetic sequences for scientific purposes; Development and test of enzyme production methods; Evaluations, estimates, research and preparing related reports and technical documentation of genetic materials all in the field of enzymatic production; Scientific and technological services in the field of biotechnology consisting of the development of innovative processes to produce synthetic genes; Genetic engineering, namely, production of nucleic acid sequences; Research and development services relating to the creation of synthetic nucleic acid sequences; Genetic engineering services being the design, development, and testing of synthetic gene sequences; Design, development, rental and leasing of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids and genetic materials; Genetic engineering services, namely, manufacture of synthetic DNA, RNA, genes and oligonucleotides for others; Genetic engineering and scientific laboratory services being the design, development and testing of synthetic gene sequences in complex gene production; Research and development services in the field of nucleic acid synthesis technology; Technical consulting in the field of biotechnology; Genetic engineering, namely, production of complex gene sequences; Consultancy, advisory and information services related to the aforementioned services; Software-as-a-Service (SaaS) services featuring software with a bioinformatics algorithm for use in designing gene assembly paths; Platform-as-a Service (PaaS) services featuring software platforms with a bioinformatics algorithm for use in designing gene assembly paths.

Publicações

Histórico de despachos e eventos da marca no USPTO.

15 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

27/05/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

27/05/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/04/2025

PUBO

PUBLISHED FOR OPPOSITION

08/04/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/04/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

13/03/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/03/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/03/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/03/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

18/12/2024

GNRT

NON-FINAL ACTION E-MAILED

18/12/2024

CNRT

NON-FINAL ACTION WRITTEN

18/12/2024

DOCK

ASSIGNED TO EXAMINER

04/12/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

22/11/2024

NWAP

NEW APPLICATION ENTERED

20/05/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CIMBAN ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.